Search

Your search keyword '"M. Priest"' showing total 11 results
Start Over Author "M. Priest" Journal journal of hepatology
11 results on '"M. Priest"'

2. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes

Author

Fiona Marra, J. Morris, M. Priest, C. Fleming, E. Reilly, Ray Fox, M. Heydtmann, Alison Boyle, and Stephen T. Barclay

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, business.industry, Ribavirin, Real world outcomes, medicine.disease, Sofosbuvir/velpatasvir, Gastroenterology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, Internal medicine, Genotype, medicine, 030211 gastroenterology & hepatology, 030212 general & internal medicine, business
Published
2018
Full Text
View/download PDF

4. Successful management of drug interactions with ritonavir-containing hepatitis C virus regimens in routine clinical practice

Author

Alison Boyle, Fiona Marra, M. Priest, C. Fleming, Ray Fox, S. Datta, E. Reilly, Stephen T. Barclay, and M. Heydtmann

Subjects
Drug, Hepatology, business.industry, media_common.quotation_subject, Hepatitis C virus, Medicine, Routine clinical practice, Ritonavir, business, medicine.disease_cause, Virology, media_common, medicine.drug
Published
2017
Full Text
View/download PDF

5. Sofosbuvir/Daclatsavir/Ribavirin for 12 Weeks in Patients with Genotype 3 Hepatitis C and Advanced Fibrosis/Cirrhosis: Results from a Real World Cohort

Author

M. Heydtmann, Stephen T. Barclay, Fiona Marra, Ray Fox, M. Priest, S. Datta, and O.F. Ahmed

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, Sofosbuvir, business.industry, Ribavirin, Hepatitis C, medicine.disease, Gastroenterology, Advanced fibrosis, chemistry.chemical_compound, chemistry, Internal medicine, Cohort, Genotype, medicine, In patient, business, medicine.drug
Published
2016
Full Text
View/download PDF

6. P0865 : The use of sofosbuvir based regimens amongst treatment naive and experienced patients with advanced fibrosis/cirrhosis: Real world results from a difficult to treat cohort

Author

Ray Fox, J. Morris, Stephen T. Barclay, S. Datta, M. Priest, D. Sutherland, M. Heydtmann, Adrian J. Stanley, Peter R. Mills, and Ewan Forrest

Subjects
medicine.medical_specialty, Cirrhosis, Hepatology, Sofosbuvir, business.industry, medicine.disease, Gastroenterology, Advanced fibrosis, Therapy naive, Internal medicine, Cohort, medicine, business, medicine.drug
Published
2015
Full Text
View/download PDF

10. Efficacy of Sofosbuvir/Ledipasvir in Treating Genotype 1 and 4 Hepatitis C for 8/12 Weeks: Results from a Difficult to Treat Cohort

Author

Ray Fox, Fiona Marra, M. Priest, M. Heydtmann, E. Thomson, S. Datta, O.F. Ahmed, and Stephen T. Barclay

Subjects
Ledipasvir, medicine.medical_specialty, Hepatology, Sofosbuvir, business.industry, Hepatitis C, medicine.disease, Gastroenterology, Virology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, chemistry, 030220 oncology & carcinogenesis, Internal medicine, Genotype, Cohort, medicine, 030211 gastroenterology & hepatology, business, medicine.drug
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results